Skip to main content
Erschienen in: Reactions Weekly 1/2023

01.07.2023 | Case report

Abemaciclib/palbociclib

Enterocolitis and pneumonitis: 8 case reports

Erschienen in: Reactions Weekly | Ausgabe 1/2023

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literatur
Zurück zum Zitat Kawamoto T, et al. Incidence of and risk factors for non-hematologic toxicity with combined radiotherapy and CDK4/6 inhibitors in metastatic breast cancer using dose-volume parameters analysis: a multicenter cohort study. Breast Cancer 30 : 282-292, No. 2, Mar 2023. Available from: URL: https://www.springer.com/journal/12282 Kawamoto T, et al. Incidence of and risk factors for non-hematologic toxicity with combined radiotherapy and CDK4/6 inhibitors in metastatic breast cancer using dose-volume parameters analysis: a multicenter cohort study. Breast Cancer 30 : 282-292, No. 2, Mar 2023. Available from: URL: https://​www.​springer.​com/​journal/​12282
Metadaten
Titel
Abemaciclib/palbociclib
Enterocolitis and pneumonitis: 8 case reports
Publikationsdatum
01.07.2023
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2023
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-023-42983-3

Weitere Artikel der Ausgabe 1/2023

Reactions Weekly 1/2023 Zur Ausgabe

Case report

Antineoplastics

Case report

Pembrolizumab

Case report

Multiple drugs